BD (Becton, Dickinson and Company) and Ypsomed recently expanded their collaboration to develop a 5.5 mL BD Neopak XtraFlow ...
GlobalData on MSN
BD and Ypsomed develop new version of Neopak XtraFlow syringe
The new 5.5ml BD Neopak XtraFlow Syringe uses BD’s advanced technologies, including thinner cannulas.
The 5.5mL version of the BD Neopak XtraFlow syringe is fully compatible with Ypsomed’s YpsoMate 5.5 autoinjector platform.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Ypsomed, a leading developer of injection systems, are strengthening their collaboration with the ...
6don MSN
Healthy Returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s
Structure Therapeutics CEO Ray Stevens talked about the biotech’s path forward and his expectations for the future of the ...
At MD&M West, he will present “ The Needle Boom: Scaling Overmolded Needle Manufacturing for the At Home Care Revolution ,” ...
4don MSN
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...
A new collaboration between Becton, Dickinson and Co. and Ypsomed will support the development of a 5.5-milliliter, glass, prefilled syringe designed for use with large-volume autoinjectors. The ...
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the expansion of its partnership with Ypsomed to ...
ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the commercial availability of its oral testosterone, a first-of-its-kind formulation that delivers the ...
Liz Nichols is a construction worker and artist in Portland, Ore. She posts poems and art on Instagram @graydaygoods.
The company got some bad news to start 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results